Details for New Drug Application (NDA): 018537
✉ Email this page to a colleague
NDA 018537 describes TRIDIL, which is a drug marketed by Hospira and is included in one NDA. Additional details are available on the TRIDIL profile page.
The generic ingredient in TRIDIL is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
The generic ingredient in TRIDIL is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
Summary for 018537
| Tradename: | TRIDIL |
| Applicant: | Hospira |
| Ingredient: | nitroglycerin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018537
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 5MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.5MG/ML | ||||
| Approval Date: | Jun 16, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
